Misinterpretation of sleep-induced second-degree atrioventricular block

A number of publications have claimed that Mobitz type Ⅱ atrioventricular block(AVB)may occur during sleep.None of the reports defined type Ⅱ AVB and representative electrocardiograms were either misinterpreted or missing.Relatively benign Wenckebach type Ⅰ AVB is often misdiagnosed as Mobitz type Ⅱ which is an indication for a pacemaker.Review of the published reports indicates that Mobitz type II AVB does not occur during sleep when it is absent in the awake state.Conclusion:There is no proof that sleep is associated with Mobitz type Ⅱ AVB.

Reversal of complete atrioventricular block in dialysis patients following parathyroidectomy:A case report

BACKGROUND Refractory secondary hyperparathyroidism(SHPT)is a common complication observed in patients with end-stage renal disease and can result in ectopic calcification.Metastatic calcification involving the heart valves and the conduction system can easily lead to arrhythmias,including atrioventricular block.This case report describes a maintenance hemodialysis patient with refractory SHPT resulting in a complete atrioventricular block(CAVB),which was eventually reversed to a first-degree atrioventricular block.CASE SUMMARY We present the case of a 31-year-old Asian female who was receiving maintenance hemodialysis because of lupus nephropathy.She developed SHPT,and an electrocardiogram revealed a first-degree atrioventricular block.Then,she underwent parathyroidectomy(PTX)with autotransplantation.Unfortunately,a few years later,she developed SHPT again,and an electrocardiogram revealed a CAVB.A few years after the second PTX surgery,the calcification of the left atrium and left ventricle improved,and her CAVB was reversed.CONCLUSION This case revealed that metastatic cardiac calcification can result in complete atrioventricular blockage.Following parathyroid surgery,calcification of the cardiac conduction system improved,leading to reversal of the atrioventricular block.It is important for dialysis patients to optimize intact parathyroid hormone therapy and pay attention to calcification metastasis.

Ticagrelor therapy and atrioventricular block:Do we need to worry?

Ticagrelor is a potent,direct P2Y12 antagonist with rapid onset of action and intense platelet inhibition,indicated in patients with acute coronary syndromes(ACS).This drug is usually well tolerated,but some patients experience serious adverse effects:Major bleeding;gastrointestinal disturbances;dyspnoea;ventricular pauses > 3 s.Given the unexpected high incidence of bradyarrhythmias,a PLATO substudy monitored this side effect,showing that ticagrelor was associated with an increase in the rate of sinus bradycardia and sinus arrest compared to clopidogrel.This side effect was usually transient,asymptomatic and not associated with higher incidence of severe atrioventricular(AV) block or pacemaker needs.A panel of experts from Food and Drug Administration did not consider bradyarrhythmias a serious problem in clinical practice and,accordingly,current labeling of the drug does not give any precaution or contraindication regarding this issue.However,recently some articles have described ACS patients with high-degree,life-threatening,AV block requiring drug discontinuation and,in some cases,pacemaker implantation.In this paper,we describe and discuss five published case reports of severe AV block following ticagrelor therapy and two other cases managed in our Hospital.The analysis of literature suggests that,although rarely,ticagrelor can be associated with lifethreatening AV block.Caution and careful monitoring are required especially in patients with already compromised conduction system and/or treated with AV blocking agents.Future studies,with long-term rhythm monitoring,would help to define the outcome of patients at higher risk of developing this complication.

A rare case of Staphylococcus lugdunensis septicemia associated with myocarditis and atrioventricular block

Myocarditis is a relatively rare,possibly life-threatening disease characterized by the inflammation of the myocardium.111 The disease pathogenesis is primarily initiated by acute injury and necrosis of cardiomyocytes,leading to an inflammatory response mediated by the immune system that can potentially cause further aggravation of myocardial damage and organ dysfunction.Prognosis in patients with myocarditis depends on the clinical presentation,which ranges from an asymptomatic disease course to the concomitant development of cardiac arrhythmias,heart failure,cardiogenic shock and even the occurrence of death in extreme cases[1].

Identification of a New Lamin A/C Mutation in a Chinese Family Affected with Atrioventricular Block as the Prominent Phenotype

Even though mutations in LMNA have been reported in patients with typical dilated cardio-myopathy(DCM)and atrioventricular block(AVB)previously,the purpose of this study was to disclose this novel genetic abnormality in one Chinese family with the atypical phenotype of progressive AVB followed by DCM with normal QRS interval.Genome-wide linkage analysis mapped the AVB gene in this family to a marker at chromosome 1q21.2,where the LMNA gene was located.Direct DNA sequence analysis revealed a heterozygous G t...

Completed atrioventricular block induced by atrial septal defect occluder unfolding:A case report

BACKGROUND An atrial septal defect is a common condition and accounts for 25%of adult congenital heart diseases.Transcatheter occlusion is a widely used technique for the treatment of secondary aperture-type atrial septal defects(ASDs).CASE SUMMARY A 30-year-old female patient was diagnosed with ASD by transthoracic echocardiography(TTE)1 year ago.The electrocardiogram showed a heart rate of 88 beats per minute,normal sinus rhythm,and no change in the ST-T wave.After admission,TTE showed an atrial septal defect with a left-to-right shunt,aortic root short-axis section with an ASD diameter of 8 mm,a parasternal four-chamber section with an ASD diameter of 9 mm,and subxiphoid biatrial section with a diameter of 13 mm.Percutaneous occlusion was proposed.The intraoperative TTE scan showed that the atrial septal defect was oval in shape,was located near the root of the aorta,and had a maximum diameter of 13 mm.A 10-F sheath was placed in the right femoral vein,and a 0.035°hard guidewire was used to establish the transport track between the left pulmonary vein and the inferior vena cava.A shape-memory alloy atrial septal occluder with a waist diameter of 20 mm was placed successfully and located correctly.TTE showed that the double disk unfolded well and that the clamping of the atrial septum was smooth.Immediately after the disc was revealed,electrocardiograph monitoring showed that the ST interval of the inferior leads was prolonged,the P waves and QRS waves were separated,a junctional escape rhythm maintained the heart rate,and the blood pressure began to decrease.After removing the occluder,the elevation in the ST segment returned to normal immediately,and the sinus rhythm returned to average approximately 10 min later.After consulting the patient’s family,we finally decided to withdraw from the operation.CONCLUSION Compression of the small coronary artery,which provides an alternative blood supply to the atrioventricular nodule during the operation,leads to the emergence of a complete atrioventricular block.

Tako-tsubo syndrome after administration of intravenous adrenaline during atrioventricular block

We describe the clinical case of a 70-year-old woman with complete atrioventricular block that after administration of intravenous adrenaline, developed electrocardiographic changes suggestive of acute coronary syndrome, together with apical dyskinesia of the left ventricle. After ruling out the existence of coronary lesions, and after total recovery of the echocardiographic alterations in segmental contractility, she was diagnosed as Tako-tsubo syndrome induced by administration of adrenaline. This is the first report of this syndrome in the scenario of atrioventricular block treated with adrenaline infusion.

A Case of Transient Advanced Atrioventricular Block after Aortic Valve Replacement, Report of a Case

Approximately 3%-11.8% of cases require permanent pacemaker implantation due to atrioventricular block (AVB) after aortic valve replacement (AVR), and determination of conduction disturbances such as left or right bundle branch block by preoperative electrocardiography is correlated with high risk postoperative permanent pacemaker implantation. Intraoperative risk factors include severe calcification of the aortic valve, prolonged cardiopulmonary bypass time, aortic clamp time. Recently, there have been reports of high rates of pacemaker implantation (14.2%) after transcatheter aortic valve implantation. The time of permanent pacemaker implantation after AVB is often 4-10 days, and the European Society of Cardiology guidelines recommend a period of seven days of persistent atrioventricular block postsurgery prior to permanent pacemaker implantation. We report a 79-year-old woman in which the patient developed high-degree AVB after AVR was performed for severe aortic stenosis with complete right bundle branch block. However, her pulse returned to sinus rhythm 7 days postsurgery.

Outcomes in patients with COVID-19 and new onset heart blocks: Insight from the National Inpatient Sample database

BACKGROUND Coronavirus disease 2019(COVID-19)caused by the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has resulted in a worldwide health crisis since it first appeared.Numerous studies demonstrated the virus’s predilection to cardiomyocytes;however,the effects that COVID-19 has on the cardiac conduc-tion system still need to be fully understood.AIM To analyze the impact that COVID-19 has on the odds of major cardiovascular complications in patients with new onset heart blocks or bundle branch blocks(BBB).METHODS The 2020 National Inpatient Sample(NIS)database was used to identify patients admitted for COVID-19 pneumonia with and without high-degree atrioven-tricular blocks(HDAVB)and right or left BBB utilizing ICD-10 codes.The patients with pre-existing pacemakers,suggestive of a prior diagnosis of HDAVB or BBB,were excluded from the study.The primary outcome was inpatient mortality.Secondary outcomes included total hospital charges(THC),the length of hospital stay(LOS),and other major cardiac outcomes detailed in the Results section.Univariate and multivariate regression analyses were used to adjust for confounders with Stata version 17.RESULTS A total of 1058815 COVID-19 hospitalizations were identified within the 2020 NIS database,of which 3210(0.4%)and 17365(1.6%)patients were newly diagnosed with HDAVB and BBB,respectively.We observed a significantly higher odds of in-hospital mortality,cardiac arrest,cardiogenic shock,sepsis,arrythmias,and acute kidney injury in the COVID-19 and HDAVB group.There was no statistically significant difference in the odds of cerebral infarction or pulmonary embolism.Encounters with COVID-19 pneumonia and newly diagnosed BBB had a higher odds of arrythmias,acute kidney injury,sepsis,need for mechanical ventilation,and cardiogenic shock than those without BBB.However,unlike HDAVB,COVID-19 pneumonia and BBB had no significant impact on mortality compared to patients without BBB.CONCLUSION In conclusion,there is a significantly higher odds of inpatient mortality,cardiac arrest,cardiogenic shock,sepsis,acute kidney injury,supraventricular tachycardia,ventricular tachycardia,THC,and LOS in patients with COVID-19 pneumonia and HDAVB as compared to patients without HDAVB.Likewise,patients with COVID-19 pneumonia in the BBB group similarly have a higher odds of supraventricular tachycardia,atrial fibrillation,atrial flutter,ventricular tachycardia,acute kidney injury,sepsis,need for mechanical ventilation,and cardiogenic shock as compared to those without BBB.Therefore,it is essential for healthcare providers to be aware of the possible worse predicted outcomes that patients with new-onset HDAVB or BBB may experience following SARS-CoV-2 infection.

希氏束起搏与右心室心尖部起搏对房室传导阻滞患者心脏结构学参数与功能学参数影响的临床研究

目的:探究希氏束起搏(HBP)与右心室心尖部起搏(RVAP)对房室传导阻滞(AVB)患者心脏结构学参数与功能学参数的影响。方法:选取收治的104例AVB患者为研究对象,随机分为HBP组和RVAP组各52例,HBP组行HBP治疗,RVAP组行RVAP治疗,比较两组术前、术后心脏结构学参数、心脏起搏参数、心率和血流动力学参数[心率(HR)、每搏输出量(SV)、心脏指数(CI)和左室射血分数(LVEF)]及QRS时限变化情况。结果:两组手术前后心脏结构学参数左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)、室间隔厚度(IVS)、左室后壁厚度(LVPW)比较,差异均无统计学意义(均P>0.05);术中、术后1个月、术后6个月心脏起搏阈值、R波幅度、电极阻抗比较无统计学差异(均P>0.05);术前、术后1个月,两组HR、SV、CI、LVEF、QRS时限比较无统计学差异(均P>0.05);术后6个月,HBP组HR、SV、CI、LVEF显著高于RVAP组(均P<0.05),RVAP组QRS波时限显著低于HBP组(P<0.05);结论:HBP对AVB患者的电-机械同步性优于RVAP,近期心脏血流动力学及心功能稳定性良好。

左束支区域起搏对房室传导阻滞患者术后新发房性心律失常的影响

目的探讨左束支区域起搏(left bundle branch area pacing,LBBaP)对房室传导阻滞(AVB)患者术后新发心房颤动(new-onset atrial fibrillation,NOAF)和心房高频事件(atrial high rate episodes,AHREs)的影响。方法回顾性纳入84例行起搏治疗的三度房室传导阻滞(ⅢAVB)患者,根据心室电极位置分为LBBaP组(n=42)和右室间隔部起搏(RVSP)组(n=42)。比较两组患者术前术后QRS波时限(QRSd)、心室起搏参数,并发症、脑卒中事件和NOAF、AHREs发生率。结果(1)LBBaP组术后NOAF、AHREs发生率均低于RVSP组(P<0.05)。(2)LBBaP组的p-QRSd短于RVSP组(P<0.05)。(3)两组患者心室起搏参数、并发症及脑卒中事件发生率之间差异无统计学意义(P>0.05)。结论相对于右室起搏,LBBaP术后AHREs、NOAF的发生率较低,可改善患者预后。

获得性房室传导阻滞的病因学研究进展

房室传导阻滞(AVB)是引起缓慢性心律失常的主要原因。其病因分为遗传性和获得性,其中获得性因素更为常见。近年来,对获得性AVB的病因学进行探讨发现,其病因复杂,主要包括冠心病、退行性疾病、感染性疾病、风湿性或自身免疫性疾病、浸润性疾病、自主神经功能异常、甲状腺功能减退、高钾血症等。因此,早期明确获得性AVB的病因至关重要,可为其治疗提供针对性策略,以改善预后。随着现代诊疗技术的发展,更多获得性AVB病因的发现将会为其治疗提供新思路。

永久起搏器植入术后2年心房电极穿孔一例

1病例资料患者男性,70岁,因“胸痛8 h余”于2023年1月8日入院。患者入院前8 h无诱因出现胸痛,位于胸骨后,呈绞痛,深呼吸时疼痛加重,持续不缓解,伴胸闷、气短、乏力,无恶心、呕吐,无黑矇、晕厥等。既往于2020年7月27日因“二度Ⅱ型房室传导阻滞”于我院植入永久起搏器(Medtronic Advisa A3DR01 DDDR,Medtronic),起搏器电极型号:右心房Medtronic 5076-52,右心室Medtronic 5076-58,起搏器程控参数见表1。2020年冠状动脉CT血管成像(computed tomography angiography,CTA)检查提示,冠状动脉粥样硬化性心脏病,双支血管病变(前降支中段狭窄50%,回旋支远段狭窄75%),纵隔肿物。建议行冠状动脉造影检查及进一步明确纵隔占位病变性质,患者均拒绝。

李洁教授运用温阳祛瘀通脉汤治疗二度Ⅱ型房室传导阻滞经验

二度Ⅱ型房室传导阻滞属于中医“心悸”范畴,是一种较为严重的缓慢性心律失常,临床表现为心悸、头晕、乏力、黑朦甚至晕厥,严重者可危及生命。二度Ⅱ型房室传导阻滞心电图表现为P波规律出现,PR间期恒定不变,部分P波后QRS波脱漏。西医在治疗二度Ⅱ型房室传导阻滞时主要应用抗心律失常药物和安装人工心脏起搏器,然而抗心律失常药物的不良反应及禁忌证较多,在临床用药时对医生及患者产生极大困扰;人工心脏起搏器的电极放电会直接导致心肌损伤,并会长期存在心肌细胞慢性炎症反应。西药治疗和介入治疗均存在不可避免的弊端,因此临床上患者接纳程度普遍偏低。李洁教授从中医角度分析认为本病为本虚标实之证,本虚的病机多为心阳不振或气血亏虚,标实的病机多为痰饮停滞或瘀血阻滞。温阳祛瘀通脉汤是李洁教授根据其治疗心血管疾病的30多年临床经验总结创立而成,具有温通心阳、活血化瘀、益气复脉之功,主要用于治疗二度Ⅱ型房室传导阻滞,可明显改善患者症状,阻止病情进展,收效甚佳。现根据一则验案分析李洁教授运用温阳祛瘀通脉汤诊治二度Ⅱ型房室传导阻滞的思路与经验。

左束支起搏和右室心尖部起搏在老年房室传导阻滞患者中的临床疗效比较

目的比较左束支起搏(left bundle branch pacing,LBBP)和右室心尖部起搏(right ventricular apical pacing,RVAP)治疗老年房室传导阻滞(atrioventricular block,AVB)患者的临床效果。方法回顾性分析2016年1月—2021年6月因AVB于同济大学附属第十人民医院行永久起搏器植入术256例患者(≥65岁)的临床资料,根据起搏方式将患者分为RVAP组(n=121)和LBBP组(n=135)。比较两组起搏方式的临床疗效。结果两组患者基线资料均无明显统计学差异。两组患者的起搏参数(阈值、感知和阻抗)在术中、术后7 d、术后1年差异均无统计学意义(均P>0.05),但LBBP组患者术后QRS波群时限明显缩短(均P<0.001)。术后1年随访中,与RVAP组相比,LBBP组起搏术式显著改善患者心功能,如左室射血分数、左心室舒张末期内径、NT-proBNP表达水平(均P<0.05)。此外,LBBP组和RVAP组相比,并发症发生率和起搏器依赖患者比例无显著差异(均P>0.05),但LBBP患者术后1年内再住院率显著降低(P=0.004)。进一步行Logistic回归分析发现LBBP起搏术式与老年AVB患者的再住院率有关(全部进入模式P=0.014,向前逐步回归模式P=0.010)。Kaplan-Meier累积事件曲线的比较显示RVAP和LBBP的累积再住院率有显著统计学差异(P=0.003)。ROC曲线分析也揭示了不同起搏术式对老年AVB患者的再住院率有预测价值(P=0.011,AUC=0.703,灵敏度=0.857,特异度=0.550)。结论与传统RVAP相比,LBBP起搏术式治疗老年AVB患者具有更好的安全性和稳定性,可有效改善患者心功能,降低患者再住院率。

基于“温三焦之阳,理气化痰通脉”法则论治房室传导阻滞

房室传导阻滞是发生在心房和心室之间的电激动传导异常,使心脏不能正常收缩和泵血,造成血流动力学不稳定并伴有明显临床症状。一般以心肌炎为主要病因。现代医学对房室传导阻滞的疗效有限、方法单一,而中医药的治疗效果显著、方法多样。阳虚脉阻为房室传导阻滞的主要病机,笔者以温阳通脉为法,扶助心、脾、肾三焦阳气,化痰祛瘀的同时兼顾梳理气机,取得良好疗效。

Predictors of permanent pacemaker implantation following transcatheter aortic valve replacement-the search is still on!

Several anatomical,demographic,clinical,electrocardiographic,procedural,and valve-related variables can be used to predict the probability of developing con-duction abnormalities after transcatheter aortic valve replacement(TAVR)that necessitate permanent pacemaker(PPM)implantation.These variables include calcifications around the device landing zone and in the mitral annulus;pre-existing electrocardiographic abnormalities such as left and right bundle branch blocks(BBB),first-and second-degree atrioventricular blocks,as well as bifas-cicular and trifascicular blocks;male sex;diabetes mellitus(DM);hypertension;history of atrial fibrillation;renal failure;dementia;and use of self-expanding valves.The current study supports existing literature by demonstrating that type 2 DM and baseline right BBB are significant predictors of PPM implantation post-TAVR.Regardless of the side of the BBB,this study demonstrated,for the first time,a linear association between the incidence of PPM implantation post-TAVR and every 20 ms increase in baseline QRS duration(above 100 ms).After a 1-year follow-up,patients who received PPM post-TAVR had a higher rate of hospital-ization for heart failure and nonfatal myocardial infarction.

人群房室传导阻滞患病率及危险因素研究:基于开滦队列研究

背景房室传导阻滞与心血管疾病患者不良预后相关,而我国相关流行病学数据相对缺乏,筛查并消除房室传导阻滞的危险因素以预防房室传导阻滞的发生是非常重要的。目的探讨开滦研究人群中房室传导阻滞患病率及危险因素。方法纳入参加2018—2020年健康体检的开滦集团在职员工及离退休人员作为观察对象,收集参与者的一般资料、既往史和服药史。患者空腹8 h后,于体检当日晨起抽取肘静脉血5 mL用于生化检测,同时进行心电图检查。采用多因素Logistic回归分析探讨影响房室传导阻滞的危险因素并进行敏感性分析。结果最终纳入观察对象80859名,平均年龄(53.8±14.9)岁。房室传导阻滞患病率为0.97%(786/80859),其中一度房室传导阻滞患病率为0.91%(732/80859),二度及以上房室传导阻滞患病率为0.07%(54/80859)。房室传导阻滞患者男性比例、年龄、收缩压、空腹血糖、低密度脂蛋白胆固醇、BMI、高血压、糖尿病、饮酒比例、血尿酸、服药、动脉粥样硬化性心血管疾病(ASCVD)比例高于无房室传导阻滞者,舒张压、心率低于无房室传导阻滞者(P<0.05)。进一步将研究对象按照是否患有房室传导阻滞及房室传导阻滞程度,将患者分为无房室传导阻滞组(n=80073)、一度房室传导阻滞组(n=732)和二度及以上房室传导阻滞组(n=54)。三组研究对象性别、年龄、心率、高血压、BMI、糖尿病、高尿酸血症、高低密度脂蛋白、饮酒、ASCVD比例比较,差异有统计学意义(P<0.05)。多因素Logistic回归分析结果显示男性、高龄、高血压、糖尿病、高低密度脂蛋白水平、高尿酸血症、高BMI及饮酒为房室传导阻滞的危险因素,心率增加为房室传导阻滞的保护因素(P<0.05)。结论开滦人群中房室传导阻滞患病率为0.97%,高龄、男性、高BMI、高血压、糖尿病、高低密度脂蛋白、高尿酸血症及饮酒为房室传导阻滞的危险因素,高心率为房室传导阻滞的保护因素。

经导管主动脉瓣置换术后传导阻滞及起搏器植入的预测因子研究进展

主动脉瓣狭窄(aortic stenosis,AS)是由先天或后天因素引起的瓣膜结构改变,发病率随年龄增长而升高。经导管主动脉瓣置换术(transcatheter aortic valve replacement,TAVR)是一种安全可行的重度AS微创治疗方法。自2011年被FDA首次批准应用于无法进行外科手术治疗的重度AS患者以来,其适应证不断扩展至中低手术风险AS人群。人工瓣膜植入后可压迫位于主动脉根部的房室传导系统,导致术后心脏传导异常的发生,永久起搏器植入(permanent pacemaker implantation,PPMI)是其治疗手段。TAVR术后PPMI与患者预后密切相关。因此,本文对TAVR术后传导功能障碍发生及PPMI的预测因素进行综述。

知信行健康管理干预在Ⅲ度房室传导阻滞行永久性起搏器术后患者中的应用

目的:探讨知信行健康管理干预在Ⅲ度房室传导阻滞行永久性起搏器术后患者中的应用。方法:选取2020年6月—2022年10月南华大学附属第二医院收治的92例Ⅲ度房室传导阻滞患者作为研究对象,根据随机数表法将患者分为研究组和参照组,各46例。参照组采用术后常规护理措施,研究组在参照组基础上给予知信行健康管理干预,比较两组干预前后左室射血分数(LVEF)、6分钟步行距离(6MWD)和自我护理水平,评价两组护理依从性,并对两组并发症发生情况进行比较。结果:干预后,两组LVEF和6MWD较干预前改善,且研究组LVEF和6MWD均优于参照组,差异有统计学意义(P<0.05)。干预后,两组自护能力较干预前改善,且研究组自我概念、健康知识程度、自护技能和自护责任感评分高于参照组,差异有统计学意义(P<0.05)。研究组护理总依从率为95.65%,高于参照组的76.09%,差异有统计学意义(χ^(2)=8.265,P=0.016)。研究组并发症发生率为6.52%,低于参照组的23.91%,差异有统计学意义(χ^(2)=5.333,P=0.021)。结论:知信行健康管理干预可提高Ⅲ度房室传导阻滞行永久性起搏器术后患者护理依从性和自护能力水平,改善心功能,减少并发症。